Jignesh Prajapati
@jsprajapati07
January 8th, 2010 19:30
FMCG Sales Professional ,Tech savvy,Sports lover ,Thinker,Yoga Lover,Geeky,Electric vehicle Lover, Futuristic
Jignesh Prajapati
@jsprajapati07
January 8th, 2010 19:30
FMCG Sales Professional ,Tech savvy,Sports lover ,Thinker,Yoga Lover,Geeky,Electric vehicle Lover, Futuristic
Feeds
70Following
0Followers
0Likes
0Top scripts
Overall User Sentiment
Our Sponsors
Our Sponsors
jsprajapati07
@jsprajapati07
September 1st, 2022 09:13
RT @nimeshscnbc: Jefferies on Grasim (AR Analysis) Buy, TP Raised to Rs 1970 Like for its 1)competitive edge in standalone biz 2)30%+ cap…
RT @nimeshscnbc: Jefferies on Grasim (AR Analysis) Buy, TP Raised to Rs 1970 Like for its 1)competitive edge in standalone biz 2)30%+ cap…
jsprajapati07
@jsprajapati07
September 1st, 2022 09:13
RT @nimeshscnbc: Jefferies on Grasim (AR Analysis) Buy, TP Raised to Rs 1970 Like for its 1)competitive edge in standalone biz 2)30%+ cap…
September 1st, 2022 09:13
RT @nimeshscnbc: Jefferies on Grasim (AR Analysis) Buy, TP Raised to Rs 1970 Like for its 1)competitive edge in standalone biz 2)30%+ cap…
jsprajapati07
@jsprajapati07
August 29th, 2022 21:41
RT @PRSundar64: Bought Infy Future at 1464. Sold 1560CE and used that money to buy 1360PE, so that my maximum loss is capped at about Rs 10…
RT @PRSundar64: Bought Infy Future at 1464. Sold 1560CE and used that money to buy 1360PE, so that my maximum loss is capped at about Rs 10…
jsprajapati07
@jsprajapati07
August 29th, 2022 21:41
RT @PRSundar64: Bought Infy Future at 1464. Sold 1560CE and used that money to buy 1360PE, so that my maximum loss is capped at about Rs 10…
August 29th, 2022 21:41
RT @PRSundar64: Bought Infy Future at 1464. Sold 1560CE and used that money to buy 1360PE, so that my maximum loss is capped at about Rs 10…
jsprajapati07
@jsprajapati07
August 4th, 2022 16:01
RT @nimeshscnbc: CLSA on Hindalco Buy, TP Rs 525 Novelis – best ever profitability Strong 1Q & robust guidance should allay concern Noveli…
RT @nimeshscnbc: CLSA on Hindalco Buy, TP Rs 525 Novelis – best ever profitability Strong 1Q & robust guidance should allay concern Noveli…
jsprajapati07
@jsprajapati07
August 4th, 2022 16:01
RT @nimeshscnbc: CLSA on Hindalco Buy, TP Rs 525 Novelis – best ever profitability Strong 1Q & robust guidance should allay concern Noveli…
August 4th, 2022 16:01
RT @nimeshscnbc: CLSA on Hindalco Buy, TP Rs 525 Novelis – best ever profitability Strong 1Q & robust guidance should allay concern Noveli…
jsprajapati07
@jsprajapati07
August 2nd, 2022 07:57
RT @nimeshscnbc: Cipla Review HSBC Buy, TP Rs 1180 Op. margins at 21.3% grew 322bp qoq in 1Q with price hikes, mix & cost control offset…
RT @nimeshscnbc: Cipla Review HSBC Buy, TP Rs 1180 Op. margins at 21.3% grew 322bp qoq in 1Q with price hikes, mix & cost control offset…
jsprajapati07
@jsprajapati07
August 2nd, 2022 07:57
RT @nimeshscnbc: Cipla Review HSBC Buy, TP Rs 1180 Op. margins at 21.3% grew 322bp qoq in 1Q with price hikes, mix & cost control offset…
August 2nd, 2022 07:57
RT @nimeshscnbc: Cipla Review HSBC Buy, TP Rs 1180 Op. margins at 21.3% grew 322bp qoq in 1Q with price hikes, mix & cost control offset…
jsprajapati07
@jsprajapati07
August 2nd, 2022 07:57
RT @nimeshscnbc: Cipla Review Nomura Buy, TP Rs 1195 1Q: Ahead of est Higher other operating income & lower R&D spend contributed to beat D…
RT @nimeshscnbc: Cipla Review Nomura Buy, TP Rs 1195 1Q: Ahead of est Higher other operating income & lower R&D spend contributed to beat D…
jsprajapati07
@jsprajapati07
August 2nd, 2022 07:57
RT @nimeshscnbc: Cipla Review Nomura Buy, TP Rs 1195 1Q: Ahead of est Higher other operating income & lower R&D spend contributed to beat D…
August 2nd, 2022 07:57
RT @nimeshscnbc: Cipla Review Nomura Buy, TP Rs 1195 1Q: Ahead of est Higher other operating income & lower R&D spend contributed to beat D…
jsprajapati07
@jsprajapati07
July 5th, 2022 20:47
RT @nimeshscnbc: GS on ONGC Buy, TP cut to Rs 210 from Rs 285 Windfall tax a surprise; but risk reward remains favourable Reflecting new ad…
RT @nimeshscnbc: GS on ONGC Buy, TP cut to Rs 210 from Rs 285 Windfall tax a surprise; but risk reward remains favourable Reflecting new ad…
jsprajapati07
@jsprajapati07
July 5th, 2022 20:47
RT @nimeshscnbc: GS on ONGC Buy, TP cut to Rs 210 from Rs 285 Windfall tax a surprise; but risk reward remains favourable Reflecting new ad…
July 5th, 2022 20:47
RT @nimeshscnbc: GS on ONGC Buy, TP cut to Rs 210 from Rs 285 Windfall tax a surprise; but risk reward remains favourable Reflecting new ad…
jsprajapati07
@jsprajapati07
June 17th, 2022 21:30
RT @nimeshscnbc: CLSA on Hindalco (Access Day takeaways) Buy. TP Rs 580 At 0.8x FY24 P/B, risk-reward attractive Aluminium to be in defici…
RT @nimeshscnbc: CLSA on Hindalco (Access Day takeaways) Buy. TP Rs 580 At 0.8x FY24 P/B, risk-reward attractive Aluminium to be in defici…
jsprajapati07
@jsprajapati07
June 17th, 2022 21:30
RT @nimeshscnbc: CLSA on Hindalco (Access Day takeaways) Buy. TP Rs 580 At 0.8x FY24 P/B, risk-reward attractive Aluminium to be in defici…
June 17th, 2022 21:30
RT @nimeshscnbc: CLSA on Hindalco (Access Day takeaways) Buy. TP Rs 580 At 0.8x FY24 P/B, risk-reward attractive Aluminium to be in defici…
jsprajapati07
@jsprajapati07
June 7th, 2022 20:10
RT @nimeshscnbc: Jefferies on Infosys Buy, TP cut to Rs 1830 from Rs 2050 Co well positioned to deliver 11/15% CAGR in revenue/EPS over F…
RT @nimeshscnbc: Jefferies on Infosys Buy, TP cut to Rs 1830 from Rs 2050 Co well positioned to deliver 11/15% CAGR in revenue/EPS over F…
jsprajapati07
@jsprajapati07
June 7th, 2022 20:10
RT @nimeshscnbc: Jefferies on Infosys Buy, TP cut to Rs 1830 from Rs 2050 Co well positioned to deliver 11/15% CAGR in revenue/EPS over F…
June 7th, 2022 20:10
RT @nimeshscnbc: Jefferies on Infosys Buy, TP cut to Rs 1830 from Rs 2050 Co well positioned to deliver 11/15% CAGR in revenue/EPS over F…
jsprajapati07
@jsprajapati07
June 7th, 2022 20:10
RT @nimeshscnbc: CITI on Cipla Buy, TP Rs 1170 Co has filed two peptide drugs in US & after the approval of Lanreotide, believe this is the…
RT @nimeshscnbc: CITI on Cipla Buy, TP Rs 1170 Co has filed two peptide drugs in US & after the approval of Lanreotide, believe this is the…
jsprajapati07
@jsprajapati07
June 7th, 2022 20:10
RT @nimeshscnbc: CITI on Cipla Buy, TP Rs 1170 Co has filed two peptide drugs in US & after the approval of Lanreotide, believe this is the…
June 7th, 2022 20:10
RT @nimeshscnbc: CITI on Cipla Buy, TP Rs 1170 Co has filed two peptide drugs in US & after the approval of Lanreotide, believe this is the…
jsprajapati07
@jsprajapati07
May 30th, 2022 23:12
RT @NeerajCNBC: Citi on ONGC Sell Call Target Rs 155 -- Nomura on ONGC Neutral Call Target Rs 185 @CNBC_Awaaz
RT @NeerajCNBC: Citi on ONGC Sell Call Target Rs 155 -- Nomura on ONGC Neutral Call Target Rs 185 @CNBC_Awaaz
jsprajapati07
@jsprajapati07
May 30th, 2022 23:12
RT @NeerajCNBC: Citi on ONGC Sell Call Target Rs 155 -- Nomura on ONGC Neutral Call Target Rs 185 @CNBC_Awaaz
May 30th, 2022 23:12
RT @NeerajCNBC: Citi on ONGC Sell Call Target Rs 155 -- Nomura on ONGC Neutral Call Target Rs 185 @CNBC_Awaaz